GuideOncology

Autopsy in COVID-19: biosafety and specimen collection

Summarises the precautions and recommended specimens when performing autopsies or post-mortem studies in suspected or confirmed COVID-19.

Updated 3 November 2026

When to use it

Pathology, legal and forensic medicine services dealing with a deceased person with suspected or confirmed COVID-19.

Warning

The 2020 guidance (CDC, UK Royal College of Pathologists) was written at the height of the pandemic; CDC keeps its page archived since 2022. Today standard autopsy-suite precautions reinforced for respiratory pathogens apply; follow your institution's biosafety protocol and local regulations.

Risk and principles

SARS-CoV-2 is a risk group 3 pathogen that may persist in tissues after death. The main risk for staff comes from aerosols generated during dissection. The 2020 guidance advised assessing in each case whether an autopsy was needed and, if performed, doing it in a well-ventilated room (ideally negative pressure) with minimal staff.

Keep reading in the app

  • Protective equipment
  • Recommended specimens
  • Findings and interpretation

Practical tip

The main risk for staff is aerosols generated during the autopsy (oscillating saws, lung handling): minimise them.

2 more practical tips in the app.

Reference

Official source: CDC: postmortem specimens in COVID-19 (archived page)

A support tool for healthcare professionals: it guides and does not replace clinical judgement.

Back to top